Fatigue and Oxidative Stress in Children Undergoing Leukemia Treatment

Cheryl Rodgers, Chelse Sanborn, Olga Taylor, Patricia Gundy, Alice E Pasvogel, Ida M Moore, Marilyn J. Hockenberry

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Fatigue is a frequent and distressing symptom in children undergoing leukemia treatment; however, little is known about factors influencing this symptom. Antioxidants such as glutathione can decrease symptom severity in adult oncology patients, but no study has evaluated antioxidants’ effects on symptoms in pediatric oncology patients. This study describes fatigue patterns and associations of fatigue with antioxidants represented by reduced glutathione (GSH) and the reduced/oxidized glutathione (GSH/GSSG) ratio among children receiving leukemia treatment. A repeated measures design assessed fatigue and antioxidants among 38 children from two large U.S. cancer centers. Fatigue was assessed among school-age children and by parent proxy among young children. Antioxidants (GSH and GSH/GSSG ratio) were assessed from cerebrospinal fluid at four phases during leukemia treatment. Young children had a steady decline of fatigue from the end of induction treatment through the continuation phase of treatment, but no significant changes were noted among the school-age children. Mean antioxidant scores varied slightly over time; however, the GSH/GSSG ratios in these children were significantly lower than the normal ratio. Mean GSH/GSSG ratios significantly correlated to fatigue scores of the school-age children during early phases of treatment. Children with low mean GSH/GSSG ratios demonstrated oxidative stress. The low ratios noted early in therapy were significantly correlated with higher fatigue scores during induction and postinduction treatment phases. This finding suggests that increased oxidative stress during the more intensive phases of therapy may explain the experience of fatigue children report.

Original languageEnglish (US)
Pages (from-to)515-520
Number of pages6
JournalBiological Research for Nursing
Volume18
Issue number5
DOIs
StatePublished - Oct 1 2016

Fingerprint

Fatigue
Leukemia
Oxidative Stress
Glutathione Disulfide
Antioxidants
Therapeutics
Glutathione
Proxy
Secondary Prevention
Cerebrospinal Fluid
Pediatrics

Keywords

  • fatigue
  • leukemia
  • oxidative stress
  • pediatric

ASJC Scopus subject areas

  • Research and Theory

Cite this

Fatigue and Oxidative Stress in Children Undergoing Leukemia Treatment. / Rodgers, Cheryl; Sanborn, Chelse; Taylor, Olga; Gundy, Patricia; Pasvogel, Alice E; Moore, Ida M; Hockenberry, Marilyn J.

In: Biological Research for Nursing, Vol. 18, No. 5, 01.10.2016, p. 515-520.

Research output: Contribution to journalArticle

Rodgers, Cheryl ; Sanborn, Chelse ; Taylor, Olga ; Gundy, Patricia ; Pasvogel, Alice E ; Moore, Ida M ; Hockenberry, Marilyn J. / Fatigue and Oxidative Stress in Children Undergoing Leukemia Treatment. In: Biological Research for Nursing. 2016 ; Vol. 18, No. 5. pp. 515-520.
@article{4dd6e9710aca4b9da3c073d8588fb9d2,
title = "Fatigue and Oxidative Stress in Children Undergoing Leukemia Treatment",
abstract = "Fatigue is a frequent and distressing symptom in children undergoing leukemia treatment; however, little is known about factors influencing this symptom. Antioxidants such as glutathione can decrease symptom severity in adult oncology patients, but no study has evaluated antioxidants’ effects on symptoms in pediatric oncology patients. This study describes fatigue patterns and associations of fatigue with antioxidants represented by reduced glutathione (GSH) and the reduced/oxidized glutathione (GSH/GSSG) ratio among children receiving leukemia treatment. A repeated measures design assessed fatigue and antioxidants among 38 children from two large U.S. cancer centers. Fatigue was assessed among school-age children and by parent proxy among young children. Antioxidants (GSH and GSH/GSSG ratio) were assessed from cerebrospinal fluid at four phases during leukemia treatment. Young children had a steady decline of fatigue from the end of induction treatment through the continuation phase of treatment, but no significant changes were noted among the school-age children. Mean antioxidant scores varied slightly over time; however, the GSH/GSSG ratios in these children were significantly lower than the normal ratio. Mean GSH/GSSG ratios significantly correlated to fatigue scores of the school-age children during early phases of treatment. Children with low mean GSH/GSSG ratios demonstrated oxidative stress. The low ratios noted early in therapy were significantly correlated with higher fatigue scores during induction and postinduction treatment phases. This finding suggests that increased oxidative stress during the more intensive phases of therapy may explain the experience of fatigue children report.",
keywords = "fatigue, leukemia, oxidative stress, pediatric",
author = "Cheryl Rodgers and Chelse Sanborn and Olga Taylor and Patricia Gundy and Pasvogel, {Alice E} and Moore, {Ida M} and Hockenberry, {Marilyn J.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1177/1099800416647794",
language = "English (US)",
volume = "18",
pages = "515--520",
journal = "Biological Research for Nursing",
issn = "1099-8004",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Fatigue and Oxidative Stress in Children Undergoing Leukemia Treatment

AU - Rodgers, Cheryl

AU - Sanborn, Chelse

AU - Taylor, Olga

AU - Gundy, Patricia

AU - Pasvogel, Alice E

AU - Moore, Ida M

AU - Hockenberry, Marilyn J.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Fatigue is a frequent and distressing symptom in children undergoing leukemia treatment; however, little is known about factors influencing this symptom. Antioxidants such as glutathione can decrease symptom severity in adult oncology patients, but no study has evaluated antioxidants’ effects on symptoms in pediatric oncology patients. This study describes fatigue patterns and associations of fatigue with antioxidants represented by reduced glutathione (GSH) and the reduced/oxidized glutathione (GSH/GSSG) ratio among children receiving leukemia treatment. A repeated measures design assessed fatigue and antioxidants among 38 children from two large U.S. cancer centers. Fatigue was assessed among school-age children and by parent proxy among young children. Antioxidants (GSH and GSH/GSSG ratio) were assessed from cerebrospinal fluid at four phases during leukemia treatment. Young children had a steady decline of fatigue from the end of induction treatment through the continuation phase of treatment, but no significant changes were noted among the school-age children. Mean antioxidant scores varied slightly over time; however, the GSH/GSSG ratios in these children were significantly lower than the normal ratio. Mean GSH/GSSG ratios significantly correlated to fatigue scores of the school-age children during early phases of treatment. Children with low mean GSH/GSSG ratios demonstrated oxidative stress. The low ratios noted early in therapy were significantly correlated with higher fatigue scores during induction and postinduction treatment phases. This finding suggests that increased oxidative stress during the more intensive phases of therapy may explain the experience of fatigue children report.

AB - Fatigue is a frequent and distressing symptom in children undergoing leukemia treatment; however, little is known about factors influencing this symptom. Antioxidants such as glutathione can decrease symptom severity in adult oncology patients, but no study has evaluated antioxidants’ effects on symptoms in pediatric oncology patients. This study describes fatigue patterns and associations of fatigue with antioxidants represented by reduced glutathione (GSH) and the reduced/oxidized glutathione (GSH/GSSG) ratio among children receiving leukemia treatment. A repeated measures design assessed fatigue and antioxidants among 38 children from two large U.S. cancer centers. Fatigue was assessed among school-age children and by parent proxy among young children. Antioxidants (GSH and GSH/GSSG ratio) were assessed from cerebrospinal fluid at four phases during leukemia treatment. Young children had a steady decline of fatigue from the end of induction treatment through the continuation phase of treatment, but no significant changes were noted among the school-age children. Mean antioxidant scores varied slightly over time; however, the GSH/GSSG ratios in these children were significantly lower than the normal ratio. Mean GSH/GSSG ratios significantly correlated to fatigue scores of the school-age children during early phases of treatment. Children with low mean GSH/GSSG ratios demonstrated oxidative stress. The low ratios noted early in therapy were significantly correlated with higher fatigue scores during induction and postinduction treatment phases. This finding suggests that increased oxidative stress during the more intensive phases of therapy may explain the experience of fatigue children report.

KW - fatigue

KW - leukemia

KW - oxidative stress

KW - pediatric

UR - http://www.scopus.com/inward/record.url?scp=84987761784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987761784&partnerID=8YFLogxK

U2 - 10.1177/1099800416647794

DO - 10.1177/1099800416647794

M3 - Article

C2 - 27179013

AN - SCOPUS:84987761784

VL - 18

SP - 515

EP - 520

JO - Biological Research for Nursing

JF - Biological Research for Nursing

SN - 1099-8004

IS - 5

ER -